These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9493593)

  • 1. Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B.
    Hosaka Y; Takahashi Y; Ishii H
    Thromb Haemost; 1998 Feb; 79(2):371-7. PubMed ID: 9493593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.
    Nesheim M; Wang W; Boffa M; Nagashima M; Morser J; Bajzar L
    Thromb Haemost; 1997 Jul; 78(1):386-91. PubMed ID: 9198184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin.
    Mosnier LO; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Jan; 85(1):5-11. PubMed ID: 11204587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B.
    Sakharov DV; Plow EF; Rijken DC
    J Biol Chem; 1997 May; 272(22):14477-82. PubMed ID: 9162090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
    Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma.
    Broze GJ; Higuchi DA
    Blood; 1996 Nov; 88(10):3815-23. PubMed ID: 8916945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
    Wu KK; Matijevic-Aleksic N
    Ann Med; 2000 Dec; 32 Suppl 1():73-7. PubMed ID: 11209986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
    Mosnier LO; von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
    Mosnier LO; Elisen MG; Bouma BN; Meijers JC
    Thromb Haemost; 2001 Oct; 86(4):1057-64. PubMed ID: 11686324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
    Bajzar L; Nesheim M; Morser J; Tracy PB
    J Biol Chem; 1998 Jan; 273(5):2792-8. PubMed ID: 9446587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of plasma procarboxypeptidase U in different mammalian species points to a conserved pathway of inhibition of fibrinolysis.
    Schatteman KA; Goossens FJ; Scharpé SS; Hendriks DF
    Thromb Haemost; 1999 Dec; 82(6):1718-21. PubMed ID: 10613660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.
    Von dem Borne PA; Bajzar L; Meijers JC; Nesheim ME; Bouma BN
    J Clin Invest; 1997 May; 99(10):2323-7. PubMed ID: 9153272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect.
    Bouton MC; Venisse L; Richard B; Pouzet C; Arocas V; Jandrot-Perrus M
    Circ Res; 2007 Apr; 100(8):1174-81. PubMed ID: 17379830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor (TAFI) in plasma associated with clot formation.
    Bouma BN; Mosnier LO; Meijers JC; Griffin JH
    Thromb Haemost; 1999 Dec; 82(6):1703-8. PubMed ID: 10613658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO; Lisman T; van den Berg HM; Nieuwenhuis HK; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis.
    Mosnier LO; Bouma BN
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2445-53. PubMed ID: 16960106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex.
    Fuentes-Prior P; Iwanaga Y; Huber R; Pagila R; Rumennik G; Seto M; Morser J; Light DR; Bode W
    Nature; 2000 Mar; 404(6777):518-25. PubMed ID: 10761923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
    Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
    Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology.
    Zamarron C; Lijnen HR; Van Hoef B; Collen D
    Thromb Haemost; 1984 Aug; 52(1):19-23. PubMed ID: 6495259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.